Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Lysosomal dysfunction in Down syndrome and Alzheimer mouse models is caused by v-ATPase inhibition by Tyr 682 -phosphorylated APP βCTF
Eunju Im, Ying Jiang, Philip Stavrides, et al.
Science Advances (2023) Vol. 9, Iss. 30
Open Access | Times Cited: 38

Showing 1-25 of 38 citing articles:

Recent advances in Alzheimer’s disease: Mechanisms, clinical trials and new drug development strategies
Jifa Zhang, Yinglu Zhang, Jiaxing Wang, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 135
Lysosomal acidification dysfunction in microglia: an emerging pathogenic mechanism of neuroinflammation and neurodegeneration
Joseph D. Quick, Cristian Silva, Jia Hui Wong, et al.
Journal of Neuroinflammation (2023) Vol. 20, Iss. 1
Open Access | Times Cited: 60
Mechanisms of autophagy–lysosome dysfunction in neurodegenerative diseases
Ralph A. Nixon, David C. Rubinsztein
Nature Reviews Molecular Cell Biology (2024) Vol. 25, Iss. 11, pp. 926-946
Closed Access | Times Cited: 54
Defective lysosomal acidification: a new prognostic marker and therapeutic target for neurodegenerative diseases
Chih Hung Lo, Jialiu Zeng
Translational Neurodegeneration (2023) Vol. 12, Iss. 1
Open Access | Times Cited: 53
Lysosomes in senescence and aging
Xiaojun Tan, Toren Finkel
EMBO Reports (2023) Vol. 24, Iss. 11
Closed Access | Times Cited: 47
Report of the APOE4 National Institute on Aging/Alzheimer Disease Sequencing Project Consortium Working Group: Reducing APOE4 in Carriers is a Therapeutic Goal for Alzheimer's Disease
Jeffery M. Vance, Lindsay A. Farrer, Yadong Huang, et al.
Annals of Neurology (2024) Vol. 95, Iss. 4, pp. 625-634
Open Access | Times Cited: 17
Comparison of the amyloid plaque proteome in Down syndrome, early-onset Alzheimer’s disease, and late-onset Alzheimer’s disease
Mitchell Martà-Ariza, Dominique Leitner, Evgeny Kanshin, et al.
Acta Neuropathologica (2025) Vol. 149, Iss. 1
Open Access | Times Cited: 2
New precision medicine avenues to the prevention of Alzheimer’s disease from insights into the structure and function of γ-secretases
Bart De Strooper, Eric Karran
The EMBO Journal (2024) Vol. 43, Iss. 6, pp. 887-903
Open Access | Times Cited: 13
Accumulation of APP C-terminal fragments causes endolysosomal dysfunction through the dysregulation of late endosome to lysosome-ER contact sites
Marine Bretou, Ragna Sannerud, Abril Escamilla‐Ayala, et al.
Developmental Cell (2024) Vol. 59, Iss. 12, pp. 1571-1592.e9
Open Access | Times Cited: 13
The necroptosis cell death pathway drives neurodegeneration in Alzheimer’s disease
Sriram Balusu, Bart De Strooper
Acta Neuropathologica (2024) Vol. 147, Iss. 1
Open Access | Times Cited: 10
Autophagy–lysosomal-associated neuronal death in neurodegenerative disease
Ralph A. Nixon
Acta Neuropathologica (2024) Vol. 148, Iss. 1
Closed Access | Times Cited: 9
Protein mishandling and impaired lysosomal proteolysis generated through calcium dysregulation in Alzheimer’s disease
Sarah Mustaly-Kalimi, Wacey Gallegos, Robert A. Marr, et al.
Proceedings of the National Academy of Sciences (2022) Vol. 119, Iss. 49
Open Access | Times Cited: 30
The Pursuit of the “Inside” of the Amyloid Hypothesis—Is C99 a Promising Therapeutic Target for Alzheimer’s Disease?
Nobumasa Takasugi, Masato Komai, Nanaka Kaneshiro, et al.
Cells (2023) Vol. 12, Iss. 3, pp. 454-454
Open Access | Times Cited: 15
Towards a Unitary Hypothesis of Alzheimer’s Disease Pathogenesis
Estela Área-Gómez, Eric A. Schon
Journal of Alzheimer s Disease (2024) Vol. 98, Iss. 4, pp. 1243-1275
Open Access | Times Cited: 5
Exploring Potential Mechanisms Accounting for Iron Accumulation in the Central Nervous System of Patients with Alzheimer’s Disease
Steven M. LeVine
Cells (2024) Vol. 13, Iss. 8, pp. 689-689
Open Access | Times Cited: 5
Microglia degrade Alzheimer’s amyloid-beta deposits extracellularly via digestive exophagy
Rudy G Jacquet, Fernando González Ibáñez, Katherine Picard, et al.
Cell Reports (2024) Vol. 43, Iss. 12, pp. 115052-115052
Closed Access | Times Cited: 5
V-ATPase Dysfunction in the Brain: Genetic Insights and Therapeutic Opportunities
Antonio Falace, Greta Volpedo, Marcello Scala, et al.
Cells (2024) Vol. 13, Iss. 17, pp. 1441-1441
Open Access | Times Cited: 4
Intraneuronal binding of amyloid beta with reelin—Implications for the onset of Alzheimer’s disease
Asgeir Kobro‐Flatmoen, Stig W. Omholt
PLoS Computational Biology (2025) Vol. 21, Iss. 1, pp. e1012709-e1012709
Open Access
Autophagy intersection: Unraveling the role of the SNARE complex in lysosomal fusion in Alzheimer's disease
Siyu Li, Yangyang Wang, Kristina Xiao Liang, et al.
Journal of Alzheimer s Disease (2025)
Closed Access
The ER protein CANX (calnexin)-mediated autophagy protects against alzheimer disease
Hongtao Shen, Yuying Xie, Yan Wang, et al.
Autophagy (2025), pp. 1-20
Closed Access
Presenilins as hub proteins controlling the endocytic and autophagic pathways and small extracellular vesicle secretion
Inger Lauritzen, A. Bini, Anaïs Bécot, et al.
Journal of Extracellular Vesicles (2025) Vol. 14, Iss. 1
Open Access
Reduction of Cystatin B results in increased cathepsin B activity in disomic but not Trisomy 21 human cellular and mouse models
Yixing Wu, Karen Cleverley, Frances K. Wiseman
PLoS ONE (2025) Vol. 20, Iss. 1, pp. e0316822-e0316822
Open Access
Drosophila aux orchestrates the phosphorylation-dependent assembly of the lysosomal V-ATPase in glia and contributes to SNCA/α-synuclein degradation
Shiping Zhang, Linfang Wang, Shuanglong Yi, et al.
Autophagy (2025), pp. 1-20
Open Access
The future of Alzheimer’s treatment
Simon Makin
Nature (2025) Vol. 640, Iss. 8059, pp. S4-S6
Closed Access
Should evidence of an autolysosomal de-acidification defect in Alzheimer and Parkinson diseases call for caution in prescribing chronic PPI and DMARD?
Sandy Giuliano, Christopher Montemagno, Marie Angela Domdom, et al.
Autophagy (2023) Vol. 19, Iss. 10, pp. 2800-2806
Open Access | Times Cited: 8
Page 1 - Next Page

Scroll to top